ENTPD1 and relapsing-remitting multiple sclerosis: The percentage of cells expressing the suppressive marker CD39 was lower in patients’ Tregs, which might be related to the fact that this marker was mostly expressed on activated Tregs that were also tendentially lower in patients with RRMS.